Question

A 34-year-old male presents with episodic palpitations, hypertension, and ataxia. Urinary studies show very high normetanephrine but normal metanephrine. CT abdomen reveals a large adrenal mass. What is the most likely underlying syndrome?

• A. NF-1
• B. MEN
• C. VHL
• D. SDHB

Hint:

Pheochromocytoma Biochemical Signatures:
MEN 2: Adrenergic phenotype $\rightarrow$ High Metanephrine AND High Normetanephrine.
VHL and SDHx: Noradrenergic phenotype $\rightarrow$ High Normetanephrine ONLY (Normal Metanephrine). If ataxia is present, immediately suspect VHL due to cerebellar hemangioblastomas.

Answer 1

The Correct Option is C

Concept:
A young adult male presents with a massive, functional adrenal tumor causing episodic, dangerous hypertension and severe palpitations. This presentation is indisputably diagnostic of a classical Pheochromocytoma.
The core clinical task is to analyze the very specific biochemical secretory profile of the tumor (high normetanephrine, normal metanephrine) in combination with his highly specific concomitant neurological symptom (cerebellar ataxia) to pinpoint the exact underlying genetic syndrome.
Explanation:
• A pheochromocytoma is a rare, life-threatening catecholamine-secreting tumor originating from the chromaffin cells of the adrenal medulla.

• Approximately 30% to 40% of all pheochromocytomas are directly associated with hereditary genetic syndromes, most notably Multiple Endocrine Neoplasia Type 2 (MEN2), von Hippel-Lindau (VHL) syndrome, Neurofibromatosis Type 1 (NF-1), and SDHx gene mutations.

• These tumors can be elegantly distinguished by their distinct, unique biochemical secretory phenotypes.

• Pheochromocytomas associated with MEN2 (Option B) strongly express the specific enzyme PNMT (Phenylethanolamine N-methyltransferase), which converts norepinephrine into epinephrine. Therefore, these tumors primarily secrete epinephrine, and laboratory tests classically reveal prominently elevated levels of both metanephrine and normetanephrine (the adrenergic phenotype).

• In sharp contrast, tumors associated with VHL (Option C) and SDHx mutations almost entirely lack the PNMT enzyme. As a result, they can only secrete norepinephrine. Their biochemical signature is highly specific: a massive, isolated elevation in normetanephrine with completely normal metanephrine levels (the strictly noradrenergic phenotype).

• The clinical vignette specifically provides a critical, distinguishing neurological clue: the patient is suffering from prominent ataxia.

• Severe cerebellar ataxia is the absolute hallmark clinical presentation of a cerebellar hemangioblastoma.

• The combination of a noradrenergic pheochromocytoma alongside a cerebellar hemangioblastoma is the textbook, defining clinical presentation of von Hippel-Lindau (VHL) syndrome, an autosomal dominant disorder caused by a mutation in the VHL tumor suppressor gene.

• While SDHB mutations (Option D) also produce a noradrenergic biochemical profile, they are much more heavily associated with highly malignant, extra-adrenal paragangliomas, and entirely lack the classic association with cerebellar hemangioblastomas.
Final Answer:
The highly specific combination of a purely noradrenergic pheochromocytoma (high normetanephrine only) and cerebellar ataxia (indicating a hemangioblastoma) strongly points to von Hippel-Lindau (VHL) syndrome.